It is important to measure speed-to-therapy for specialty drugs to evaluate how much time it takes manufacturers, physicians, insurance companies, hubs, and specialty pharmacies to get essential medications to patients.
Marc Duey, MSc, MBA, president, ProMetrics
Advertisement
Articles by Marc Duey, MSc, MBA, president, ProMetrics
Advertisement
Latest Updated Articles
Speed-to-Therapy Insights in Specialty PharmacyNovember 14th 2013
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Accepts NDA for AD109 for Treatment of Adults With Obstructive Sleep Apnea
2
Pharmacists at the Forefront: Initiating, Monitoring, and Identifying Candidates for VMAT2 Therapy
3
Workforce Preparation for Fall Immunization Season Starts Now
4
Clinical Forum Events Highlight the Evolving Landscape of Obesity Management
5